Stem cells from umbilical cord or placenta infused into a vein for cerebral palsy
Tests the safety of stem cell infusions in people with cerebral palsy.
Key facts
- Who runs it
- The Foundation for Orthopaedics and Regenerative Medicine
- Where
- Naples, United StatesSee the siteAlso in 1 other country, 1 site
- Trial code
- Registry title
- Safety of Cultured Umbilical or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for CP
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 15 people, planned
- Starts
- Dec 2026
- Expected to end
- Dec 2028
- Type of study
- Interventional
- Treatments tested
- Umbilical or placental derived mesenchymal stem cells
- Record updated
- 16 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with cerebral palsy. They get one drip into a vein of stem cells taken from umbilical cord or placenta.
- Sex
- All sexes can join.
- Disease stage
- A diagnosis of cerebral palsy.
- Earlier treatment
- People who have had an organ transplant before cannot join.
Main reasons for not taking part
- Active infection or active cancer
- Long-term failure of several organs
- Pregnancy
- Seizure disorder (epilepsy)
- Allergy to sulfur, or clearly abnormal blood tests before treatment
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Diagnosis of Cerebral Palsy
Who cannot take part
- Previous organ transplant
- Active infection
- Active cancer
- Chronic multisystem organ failure
- Medical condition that would (based on the opinion of the investigator) compromise patient's safety
- Seizure disorder
- Hypersensitivity to sulfur
- Clinically significant Abnormalities on pre-treatment laboratory evaluation
- Pregnancy
Where in United States
Also in 1 other country, 1 site
- Prodromos Stem Cell InstituteNaples, United StatesContact: Chadwick Prodromos, MDTaking people
About the trial
What the trial wants to find out
This trial will study the safety and efficacy of intravenous infusion of cultured umbilical or placental derived mesenchymal stem cells for the treatment of Cerebral Palsy
The group in the trial
- Treatment GroupTreatment being tested
Single intravenous infusion of 100 million cells
Treatment: Umbilical or placental derived mesenchymal stem cells
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Safety of Cultured Umbilical or Placental Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Cerebral Palsy
- Plain-language title
- Stem cells from umbilical cord or placenta infused into a vein for cerebral palsyGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 16 October 2026